HCG
❄️Lyophilized powder
Größe:
Rabatt pro Menge
| Menge | Rabatt | Preis pro Einheit |
|---|---|---|
| 5 - 10 | 10% | €39.59 |
| 11 - 20 | 15% | €37.39 |
| 21+ | 20% | €35.19 |
Strenge Tests durch unabhängige Labore
Jede Charge unserer Forschungschemikalien und Peptide wird von einem unabhängigen Labor auf Reinheit und Identität geprüft.
Gesamt: €43.99
For laboratory research use only by qualified professionals. Not for human or veterinary use. Not for ingestion, injection, topical application, diagnostic, therapeutic, prophylactic or cosmetic use.
HCG is supplied as a catalogued research material in 5000 IU and 10000 IU; IU denotes biological activity, not mass. It is intended only for controlled analytical, biochemical and non-clinical laboratory workflows. The catalogue amount identifies the nominal vial presentation; it is not a dose or a use instruction.
“HCG” does not establish whether the material is urinary-derived hCG, recombinant choriogonadotropin alfa or another preparation. These materials can differ in glycosylation, impurities, potency and controls. IU states biological activity rather than molecular or protein mass; source, identity and specific activity require a signed specification and matching batch evidence [1–3].
Product identity
Identity must be assigned to the exact batch rather than to a marketed name alone. Sequence, terminal modifications, conjugation, salt or counter-ion, hydration state and excipients may change the applicable mass and registry identifiers. The batch CoA and SDS take precedence over literature identifiers shown below.
Chemical properties and registry information
| Property | Value |
|---|---|
| Name and synonyms | Human chorionic gonadotropin; hCG; exact urinary or recombinant source unconfirmed |
| Material category | Heterodimeric glycoprotein hormone; source and glycoform unresolved; prescription-medicine-related high-risk material |
| Sequence or structural definition | Mature alpha subunit: 92 amino acids; mature beta subunit: 145 amino acids; heterogeneous N- and O-linked glycans |
| Molecular formula | Not assignable to an unspecified glycoprotein preparation; glycan composition and source vary |
| Average molecular mass | No single batch mass is assigned; 5000 IU and 10000 IU are activity units and cannot be converted to mass without a validated potency assay and specific activity |
| CAS Registry Number | Not assigned to the catalogue batch; source, construct and glycoform are unresolved |
| PubChem CID | No batch assignment; the choriogonadotropin alfa record describes a specific recombinant reference, not an unspecified HCG vial |
| Structural features | Disulfide-rich alpha/beta heterodimer with heterogeneous glycosylation; source, expression system, glycan profile, subunit assembly and specific activity require batch confirmation |
| Physical form | Catalogue vial; the exact physical state, salt or counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
| Catalogue presentations | 5000 IU and 10000 IU; IU denotes biological activity, not mass |
| Batch identity and quality documentation | Lot-specific identity and available analytical reports must be verified against the CoA entry associated with the exact product size and batch. |
| Intended use | Analytical, biochemical and non-clinical laboratory research only; all human and veterinary uses are excluded. |
Where an identifier is qualified or omitted, no unambiguous exact-form public assignment has been confirmed. Do not transfer an identifier from a related analogue, salt, conjugate or formulation.
Research context and evidence status
What the literature supports
A fully characterized hCG preparation can support immunoassay, receptor-binding, glycoprotein-characterization and potency-method research. Those workflows require source-specific reference standards, subunit identity, glycan characterization and a validated activity assay.
Evidence limitations
Evidence and authorization for separately manufactured urinary or recombinant prescription medicines do not verify this catalogue vial. They do not establish its source, identity, purity, potency, viral safety, sterility, efficacy, dosage, administration or interchangeability [1–3].
Authorised hCG products are prescription medicines, FDA states they are not approved for weight loss, and hCG is covered by current anti-doping restrictions. This creates very high regulatory and payment-provider risk. No human-use or medicinal-product status is implied for these catalogue variants [2–4].
| Important | Research-use labeling does not itself determine the substance-specific legal status. The purchaser is responsible for confirming institutional authorization, local restrictions and lawful procurement, possession, import, export, storage and disposal. |
Technical comparison
The comparison below is limited to structural and analytical distinctions. It does not compare clinical performance or recommend a use.
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | Catalogue HCG with unresolved urinary/recombinant source and glycoform | Defined recombinant choriogonadotropin alfa reference or authorised finished medicine |
| Structural distinction | Source, expression system, glycan distribution, excipients and specific activity are not publicly resolved | Manufacturing source, glycoprotein controls, potency and formulation are specified |
| Analytical implication | Requires subunit identity, glycan profile, purity/aggregates, source-impurity controls and validated IU potency | Reference values apply only to the matching source, construct, glycoform and potency method |
| What is not implied | No conclusion about human or veterinary safety, efficacy, dosage, route, duration or interchangeability. | No conclusion about human or veterinary safety, efficacy, dosage, route, duration or interchangeability. |
Quality and batch documentation
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Laboratory handling and storage
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
This page intentionally provides no reconstitution, administration or dosing instructions. Laboratory preparation, analytical method selection, risk assessment, personal protective equipment and waste disposal must be defined by the qualified institution and the applicable SDS.
Regulatory and legal status
This catalogue material is not offered as a medicine, medical device, in-vitro diagnostic, food, dietary supplement, cosmetic or veterinary product. It is not intended to diagnose, treat, cure, mitigate or prevent any disease or condition.
A research designation does not override medicinal-product, controlled-substance, chemical, customs or other substance-specific rules. Availability may be restricted by jurisdiction and by the purchaser's verified professional or institutional status.
Sources and references
References document identity and research context only. They do not constitute instructions for use or evidence that this catalogue batch is suitable for any human or veterinary purpose.
- [1] PubChem. Choriogonadotropin alfa: recombinant glycoprotein reference description.
- [2] European Medicines Agency. Ovitrelle: authorised prescription choriogonadotropin alfa medicine.
- [3] U.S. FDA. Questions and answers on HCG products for weight loss.
- [4] World Anti-Doping Agency. 2026 Prohibited List.
Frequently Asked Questions
What is this material intended for?
Controlled laboratory research by qualified professionals, including substantiated analytical, biochemical or non-clinical workflows. It is not intended for personal use.
Is the amount shown on the vial a dosage?
No. It is a nominal catalogue presentation used to identify the product variant. It is not a dose, concentration, administration schedule or preparation instruction.
Do the CAS number and PubChem CID apply to every batch form?
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
What does an analytical purity result mean?
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
How should the material be stored and handled?
Follow the exact label, batch CoA and SDS, together with the institution's risk assessment. This page does not provide reconstitution or administration guidance.
May this material be used in humans or animals?
No. Human and veterinary use, including ingestion, injection, topical application, diagnosis, treatment, prevention and cosmetic use, is expressly excluded.
RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. THE PRODUCT NAME, VIAL AMOUNT AND LITERATURE REFERENCES MUST NOT BE INTERPRETED AS A DOSAGE, ADMINISTRATION INSTRUCTION OR MEDICAL CLAIM.
LABORATORY RESEARCH MATERIAL — FOR QUALIFIED PROFESSIONAL USE ONLY
For analytical, biochemical or non-clinical laboratory research only. Not for human or veterinary use. Not for ingestion, injection, topical application, inhalation, diagnostic, therapeutic, prophylactic or cosmetic use.
Mandatory conditions:
- Restricted to qualified professionals acting for verified laboratories, universities, companies or other research institutions.
- The product name and nominal catalogue presentation are identifiers; they are not a dose, concentration, preparation protocol, ingestion instruction or administration instruction.
- Before laboratory work, verify the exact material identity, sequence or structure, physical form, fill, salt or counter-ion, lot number and matching CoA and SDS.
- Storage, handling, PPE, exposure response and disposal must follow the exact label, batch documentation, SDS and an institution-approved risk assessment.
- The purchaser is responsible for institutional authorization and for jurisdiction-specific rules governing procurement, import, export, possession, storage and disposal.
- Keep secured, correctly identified and inaccessible to children and all unauthorized persons.